Eight Stocks posting Heavy Swings to Watch for Monday


Smith & Wesson Holding Corporation (NASDAQ:SWHC) traded as high as $7.09 during Friday’s trading session and last traded at $7.02 for a gain of 24.03% from the previous close… SWHC shares have traded as high as $5.53 over the past 52 weeks, which is 26.94% over that high at last traded stock price. Get my next ALERT 100% FREE

Smith & Wesson Holding Corporation manufactures an array of pistols, revolvers, tactical rifles, hunting rifles, black powder firearms, handcuffs, and firearm-related products and accessories.

Rare Element Resources Ltd. Ordinary Shares (AMEX:REE) traded as high as $6.20 during Friday’s trading session and last traded at $6.16 for a gain of 20.55% from the previous close… REE shares have traded as high as $16.55 over the past 52 weeks, which is 62.78% off that high at last traded stock price.


Rare Element Resources Ltd. is a publicly traded mineral resource company focused on exploration and development of rare-earth elements and gold. In addition to the REE exploration and evaluation efforts, the Company is exploring for gold on the Sundance project, which is located on the same property in Wyoming.

Coffee Holding Co., Inc. (NASDAQ:JVA) traded as high as $10.97 during Friday’s trading session and last traded at $10.93 for a gain of 39.24% from the previous close… JVA shares have traded as high as $30.98 over the past 52 weeks, which is 64.72% off that high at last traded stock price.

Coffee Holding Company, Inc. is an integrated wholesale coffee roaster and dealer in the United States. Its core products can be divided into three categories: Wholesale Green Coffee; Private Label Coffee; and Branded Coffee.

Aastrom Biosciences, Inc. (NASDAQ:ASTM) traded as high as $2.72 during Friday’s trading session and last traded at $2.25 for a gain of 23.63% from the previous close… ASTM shares have traded as high as $3.47 over the past 52 weeks, which is 35.16% off that high at last traded stock price.

Aastrom Biosciences, Inc. is regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Dynegy Inc. (NYSE:DYN) traded as low as $.59 during Friday’s trading session and last traded at $.75 for a loss of 36.44% from the previous close… DYN shares have traded as high as $6.92 over the past 52 weeks, which is 89.16% off that high at last traded stock price. Get my next ALERT 100% FREE

Dynegy, Inc. is an holding company conducts substantially all of its business operations through its subsidiaries. Its business is the production and sale of electric energy, capacity and ancillary services.

Peregrine Pharmaceuticals (NASDAQ:PPHM) traded as low as $.63 during Friday’s trading session and last traded at $.65 for a loss of 27.78% from the previous close… PPHM shares have traded as high as $2.74 over the past 52 weeks, which is 76.28% off that high at last traded stock price.

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company that manufactures and develops monoclonal antibodies for the treatment of cancer and serious viral infections.

Zogenix, Inc. (NASDAQ:ZGNX) traded as low as $2 during Friday’s trading session and last traded at $2.05 for a loss of 17.67% from the previous close… ZGNX shares have traded as high as $6.61 over the past 52 weeks, which is 68.99% off that high at last traded stock price.

Zogenix, Inc. is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) traded as low as $2.25 during Friday’s trading session and last traded at $3.24 for a loss of 47.23% from the previous close… ANTH shares have traded as high as $9.08 over the past 52 weeks, which is 64.32% off that high at last traded stock price.

Anthera Pharmaceuticals Inc. is a biopharmaceutical Company which focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases.

More Posts by this author


Post Written By: Oliver Crowne

Oliver Crowne is the main editor for http://www.StockPreacher.com


Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...